Skip to main content
Top
Published in: Respiratory Research 1/2005

Open Access 01-12-2005 | Research

Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models

Authors: Monica Lucattelli, Barbara Bartalesi, Eleonora Cavarra, Silvia Fineschi, Benedetta Lunghi, Piero A Martorana, Giuseppe Lungarella

Published in: Respiratory Research | Issue 1/2005

Login to get access

Abstract

Background

The separation of emphysema from fibrosis is not as clear-cut as it was thought in early studies. These two pathologies may be present at the same time in human lungs and in mice either instilled with elastolytic enzymes or bleomycin or exposed to cigarette-smoke. According to a current view, emphysema originates from a protease/antiprotease imbalance, and a role for antiproteases has also been suggested in the modulation of the fibrotic process. In this study we investigate in experimental animal models of emphysema and fibrosis whether neutrophil elastase may constitute a pathogenic link between these two pathologies.

Methods

This study was done in two animal models in which emphysema and fibrosis were induced either by bleomycin (BLM) or by chronic exposure to cigarette-smoke. In order to assess the protease-dependence of the BLM-induced lesion, a group mice was treated with 4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride, a serine proteinase inhibitor active toward neutrophil elastase. Lungs from each experimental group were used for the immunohistochemical assessment of transforming growth factor-β (TGF-β) and transforming growth factor-α (TGF-α) and for determination of the mean linear intercept as well as the percent volume densities of fibrosis and of emphysematous changes. Additionally, the lungs were also assessed for desmosine content and for the determination of elastase levels in the pulmonary interstitium by means of immunoelectron microscopy.

Results

We demonstrate that in BLM-treated mice (i) the development of elastolytic emphysema precedes that of fibrosis; (ii) significant amount of elastase in alveolar interstitium is associated with an increased expression of TGF-β and TGF-α; and finally, (iii) emphysematous and fibrotic lesions can be significantly attenuated by using a protease inhibitor active against neutrophil elastase.
Also, in a strain of mice that develop both emphysema and fibrosis after chronic cigarette-smoke exposure, the presence of elastase in alveolar structures is associated with a positive immunohistochemical reaction for reaction for both TGF-β and TGF-α.

Conclusion

The results of the present study strongly suggest that neutrophil elastase may represent a common pathogenic link between emphysema and fibrosis. Proteases and in particular neutrophil elastase could act as regulatory factors in the generation of soluble cytokines with mitogenic activity for mesenchymal cells resulting either in emphysema or in fibrosis or both.
Literature
1.
go back to reference Bartalesi B, Cavarra E, Fineschi S, Lucattelli M, Lunghi B, Martorana PA, Lungarella G: Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur Respir J 2005, 25:15–22.CrossRefPubMed Bartalesi B, Cavarra E, Fineschi S, Lucattelli M, Lunghi B, Martorana PA, Lungarella G: Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants. Eur Respir J 2005, 25:15–22.CrossRefPubMed
2.
go back to reference Lucey EC, Ngo HQ, Agarwal A, Smith BD, Snider GL, Goldstein R: Differential expression of elastin and α l (I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis. Lab Invest 1996, 74:12–20.PubMed Lucey EC, Ngo HQ, Agarwal A, Smith BD, Snider GL, Goldstein R: Differential expression of elastin and α l (I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis. Lab Invest 1996, 74:12–20.PubMed
3.
go back to reference Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T, Nukiwa T: Simultaneous or delayed administration of hepatocyte growth factor, equally represses the fibrotic changes in murine lung injury induced by bleomycin. Am J Respir Crit Care Med 1997, 156:1937–1944.CrossRefPubMed Yaekashiwa M, Nakayama S, Ohnuma K, Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T, Nukiwa T: Simultaneous or delayed administration of hepatocyte growth factor, equally represses the fibrotic changes in murine lung injury induced by bleomycin. Am J Respir Crit Care Med 1997, 156:1937–1944.CrossRefPubMed
4.
go back to reference Cavarra E, Martorana PA, Bartalesi B, Fineschi S, Gambelli F, Lucattelli M, Ortiz L, Lungarella G: Genetic deficiency of α l -PI in mice influences lung responses to bleomycin. Eur Respir J 2001, 17:474–480.CrossRefPubMed Cavarra E, Martorana PA, Bartalesi B, Fineschi S, Gambelli F, Lucattelli M, Ortiz L, Lungarella G: Genetic deficiency of α l -PI in mice influences lung responses to bleomycin. Eur Respir J 2001, 17:474–480.CrossRefPubMed
5.
go back to reference Niewoehner DE, Hoidal JR: Lung fibrosis and emphysema: divergent responses to a common injury? Science 1982, 217:359–360.CrossRefPubMed Niewoehner DE, Hoidal JR: Lung fibrosis and emphysema: divergent responses to a common injury? Science 1982, 217:359–360.CrossRefPubMed
6.
go back to reference Lang MR, Fiaux GW, Gillooy M, Stewart JA, Hulmes DJS, Lamb D: Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax 1994, 49:319–326.CrossRefPubMedPubMedCentral Lang MR, Fiaux GW, Gillooy M, Stewart JA, Hulmes DJS, Lamb D: Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs. Thorax 1994, 49:319–326.CrossRefPubMedPubMedCentral
7.
go back to reference American Thoracic Society: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002, 165:277–304.CrossRef American Thoracic Society: American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002, 165:277–304.CrossRef
8.
go back to reference Tuder RM, Voelkel NF: The pathobiology of chronic bronchitis and emphysema. In Chronic obstructive pulmonary disease. Edited by: Voelkel NF, MacNee W. Hamilton, Ontario, Canada: BC Decker Inc; 2002:90–113. Tuder RM, Voelkel NF: The pathobiology of chronic bronchitis and emphysema. In Chronic obstructive pulmonary disease. Edited by: Voelkel NF, MacNee W. Hamilton, Ontario, Canada: BC Decker Inc; 2002:90–113.
9.
go back to reference Snider GL, Martorana PA, Lucey EC, Lungarella G: Animal models of emphysema. In Chronic obstructive pulmonary disease. Edited by: Voelkel NF, MacNee W. Hamilton, Ontario, Canada: BC Decker Inc; 2002:237–256. Snider GL, Martorana PA, Lucey EC, Lungarella G: Animal models of emphysema. In Chronic obstructive pulmonary disease. Edited by: Voelkel NF, MacNee W. Hamilton, Ontario, Canada: BC Decker Inc; 2002:237–256.
10.
go back to reference Nagai A, Aoshiba K, Ishihara Y, Inano H, Sakamoto K, Yamaguchi E, Kagawa J, Takizawa T: Administration of α l -proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis 1992, 145:651–658.CrossRefPubMed Nagai A, Aoshiba K, Ishihara Y, Inano H, Sakamoto K, Yamaguchi E, Kagawa J, Takizawa T: Administration of α l -proteinase inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am Rev Respir Dis 1992, 145:651–658.CrossRefPubMed
11.
go back to reference Mitsuhashi H, Asano S, Nonaka T, Hamamura I, Masuda KI, Kiyoki M: Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am J Respir Crit Care Med 1996, 153:369–374.CrossRefPubMed Mitsuhashi H, Asano S, Nonaka T, Hamamura I, Masuda KI, Kiyoki M: Administration of truncated secretory leukoprotease inhibitor ameliorates bleomycin-induced pulmonary fibrosis in hamsters. Am J Respir Crit Care Med 1996, 153:369–374.CrossRefPubMed
12.
go back to reference Taoka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M: Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med 1997, 156:260–265.CrossRef Taoka Y, Maeda A, Hiyama K, Ishioka S, Yamakido M: Effects of neutrophil elastase inhibitor on bleomycin-induced pulmonary fibrosis. Am J Respir Crit Care Med 1997, 156:260–265.CrossRef
13.
go back to reference Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L: Elastase and α 1 -proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome: role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983, 72:656–666.CrossRefPubMedPubMedCentral Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L: Elastase and α 1 -proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome: role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983, 72:656–666.CrossRefPubMedPubMedCentral
14.
go back to reference Dunsmore S, Roes J, Chua FJ, Segal AW, Mutsaers SE, Laurent GJ: Evidence that neutrophil elastase-deficient mice are resistant to bleomycin-induced fibrosis. Chest 2001, 120:35s-36s.CrossRefPubMed Dunsmore S, Roes J, Chua FJ, Segal AW, Mutsaers SE, Laurent GJ: Evidence that neutrophil elastase-deficient mice are resistant to bleomycin-induced fibrosis. Chest 2001, 120:35s-36s.CrossRefPubMed
15.
go back to reference Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A: Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. A J Respir Cell Mol Biol 1996, 3:288–295.CrossRef Delclaux C, Delacourt C, D'Ortho MP, Boyer V, Lafuma C, Harf A: Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. A J Respir Cell Mol Biol 1996, 3:288–295.CrossRef
16.
go back to reference Gardi C, Cavarra E, Calzoni P, Marcolongo P, de Santi MM, Martorana PA, Lungarella G: Neutrophil lysosomal dysfunction in mutant C57B1/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem J 1994, 299:237–245.CrossRefPubMedPubMedCentral Gardi C, Cavarra E, Calzoni P, Marcolongo P, de Santi MM, Martorana PA, Lungarella G: Neutrophil lysosomal dysfunction in mutant C57B1/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem J 1994, 299:237–245.CrossRefPubMedPubMedCentral
17.
go back to reference Thurlbeck WM: Measurement of pulmonary emphysema. Am Rev Respir Dis 1967, 95:752–764.PubMed Thurlbeck WM: Measurement of pulmonary emphysema. Am Rev Respir Dis 1967, 95:752–764.PubMed
18.
go back to reference Cocci F, Miniati M, Monti S, Cavarra E, Gambelli F, Battolla L, Lucattelli M, Lungarella G: Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2002, 34:594–604.CrossRefPubMed Cocci F, Miniati M, Monti S, Cavarra E, Gambelli F, Battolla L, Lucattelli M, Lungarella G: Urinary desmosine excretion is inversely correlated with the extent of emphysema in patients with chronic obstructive pulmonary disease. Int J Biochem Cell Biol 2002, 34:594–604.CrossRefPubMed
19.
go back to reference Cavarra E, Martorana PA, Gambelli F, de Santi MM, van Even P, Lungarella G: Neutrophil recruitment into the lung is associated with increased lung elastase burden, decreased lung elastin, and emphysema in α 1 -proteinase inhibitor-deficient mice. Lab Invest 1996, 75:273–280.PubMed Cavarra E, Martorana PA, Gambelli F, de Santi MM, van Even P, Lungarella G: Neutrophil recruitment into the lung is associated with increased lung elastase burden, decreased lung elastin, and emphysema in α 1 -proteinase inhibitor-deficient mice. Lab Invest 1996, 75:273–280.PubMed
20.
go back to reference Cavarra E, Bartalesi B, Lucattelli M, Fineschi S, Lunghi B, Gambelli F, Ortiz LA, Martorana PA, Lungarella G: Effects of cigarette smoke in mice with different levels of αl-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med 2001, 164:886–890.CrossRefPubMed Cavarra E, Bartalesi B, Lucattelli M, Fineschi S, Lunghi B, Gambelli F, Ortiz LA, Martorana PA, Lungarella G: Effects of cigarette smoke in mice with different levels of αl-proteinase inhibitor and sensitivity to oxidants. Am J Respir Crit Care Med 2001, 164:886–890.CrossRefPubMed
21.
go back to reference Thurlbeck WM: Internal surface area of non emphysematous lungs. Am Rev Respir Dis 1967, 95:765–773.PubMed Thurlbeck WM: Internal surface area of non emphysematous lungs. Am Rev Respir Dis 1967, 95:765–773.PubMed
22.
go back to reference Weibel ER: Stereological principles for morphometry in electron microscopy cytology. Int Rev Cytol 1969, 26:235–302.CrossRefPubMed Weibel ER: Stereological principles for morphometry in electron microscopy cytology. Int Rev Cytol 1969, 26:235–302.CrossRefPubMed
23.
go back to reference McElvaney NG, Crystal RG: Inherited susceptibility of the lung to proteolytic injury. In The Lung. Edited by: Crystal RG, West JB, Weibel ER, Barnes PJ. Philadephia, USA: Lippincott-Raven; 1997:2537–2553. McElvaney NG, Crystal RG: Inherited susceptibility of the lung to proteolytic injury. In The Lung. Edited by: Crystal RG, West JB, Weibel ER, Barnes PJ. Philadephia, USA: Lippincott-Raven; 1997:2537–2553.
24.
go back to reference Selman M, King TE Jr, Pardo A: Idiopathic pulmonary fibrosis: prevailing hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001, 134:136–151.CrossRefPubMed Selman M, King TE Jr, Pardo A: Idiopathic pulmonary fibrosis: prevailing hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001, 134:136–151.CrossRefPubMed
25.
go back to reference Schrier DJ, Kunkel RG, Phan SH: The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1983, 127:63–66.CrossRefPubMed Schrier DJ, Kunkel RG, Phan SH: The role of strain variation in murine bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 1983, 127:63–66.CrossRefPubMed
26.
go back to reference Baecher-Allan CM, Barth R: PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg lmmunol 1993, 5:207–217. Baecher-Allan CM, Barth R: PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis. Reg lmmunol 1993, 5:207–217.
27.
go back to reference Reid PT, Sallenave JM: Cytokines in the pathogenesis of chronic obstructive pulmonary disease. Curr Pharm Des 2003, 9:25–38.CrossRefPubMed Reid PT, Sallenave JM: Cytokines in the pathogenesis of chronic obstructive pulmonary disease. Curr Pharm Des 2003, 9:25–38.CrossRefPubMed
28.
go back to reference Noble PW: Idiopathic pulmonary fibrosis. New insights into the classification and pathogenesis. Am J Respir Cell Mol Biol 2003, 29:S27-S31.PubMed Noble PW: Idiopathic pulmonary fibrosis. New insights into the classification and pathogenesis. Am J Respir Cell Mol Biol 2003, 29:S27-S31.PubMed
29.
go back to reference Morse D: The role of heme oxygenase-1 in pulmonary fibrosis. Am J Respir Cell Mol Biol 2003, 29:S82-S86.PubMed Morse D: The role of heme oxygenase-1 in pulmonary fibrosis. Am J Respir Cell Mol Biol 2003, 29:S82-S86.PubMed
30.
go back to reference Phan SH: Fibroblast phenotypes in pulmonary fibrosis. Am J Respir Cell Mol Biol 2003, 29:S87-S92.PubMed Phan SH: Fibroblast phenotypes in pulmonary fibrosis. Am J Respir Cell Mol Biol 2003, 29:S87-S92.PubMed
31.
go back to reference Madtes DK, Busby TP, Standjord TP, Clark JG: Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am J Respir Cell Mol Biol 1994, 11:540–551.CrossRefPubMed Madtes DK, Busby TP, Standjord TP, Clark JG: Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am J Respir Cell Mol Biol 1994, 11:540–551.CrossRefPubMed
32.
go back to reference Sime PJ, Marr RA, Gouldie D, Xing Z, Hewlett BR, Graham FL, Gauldie J: Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial flbrogenesis with induction of transforming factor-beta 1 and myofibroblasts. Am J Pathol 1998, 153:825–832.CrossRefPubMedPubMedCentral Sime PJ, Marr RA, Gouldie D, Xing Z, Hewlett BR, Graham FL, Gauldie J: Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial flbrogenesis with induction of transforming factor-beta 1 and myofibroblasts. Am J Pathol 1998, 153:825–832.CrossRefPubMedPubMedCentral
33.
go back to reference Lucattelli M, Cavarra E, de Santi MM, Tetley TD, Martorana PA, Lungarella G: Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema. Eur Respir J 2003, 22:728–734.CrossRefPubMed Lucattelli M, Cavarra E, de Santi MM, Tetley TD, Martorana PA, Lungarella G: Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema. Eur Respir J 2003, 22:728–734.CrossRefPubMed
34.
go back to reference Libert C, Van Molle W, Brouckaert P, Fiers W: α l -Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996, 157:5126–5129.PubMed Libert C, Van Molle W, Brouckaert P, Fiers W: α l -Antitrypsin inhibits the lethal response to TNF in mice. J Immunol 1996, 157:5126–5129.PubMed
35.
go back to reference Niehorster M, Tiegs G, Schade UF, Wendel A: In vivo evidence for protease-catalysed mechanism providing bioactive tumor necrosis factor α. Biochem Pharmacol 1990, 40:1601–1603.CrossRefPubMed Niehorster M, Tiegs G, Schade UF, Wendel A: In vivo evidence for protease-catalysed mechanism providing bioactive tumor necrosis factor α. Biochem Pharmacol 1990, 40:1601–1603.CrossRefPubMed
36.
go back to reference Porteu F, Brockhaus M, Wallach D, Engelmann D, Nathan CF: Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. J Biol Chem 1991, 266:18846–18853.PubMed Porteu F, Brockhaus M, Wallach D, Engelmann D, Nathan CF: Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. J Biol Chem 1991, 266:18846–18853.PubMed
37.
go back to reference Buczek-Thomas JA, Lucey EC, Stone PJ, Chu CL, Rich CB, Carreras I, Goldstein RH, Foster JA, Nugent MA: Elastase mediates the release of growth factors from lung in vivo . Am J Respir Cell Mol Biol 2004, 31:344–350.CrossRefPubMed Buczek-Thomas JA, Lucey EC, Stone PJ, Chu CL, Rich CB, Carreras I, Goldstein RH, Foster JA, Nugent MA: Elastase mediates the release of growth factors from lung in vivo . Am J Respir Cell Mol Biol 2004, 31:344–350.CrossRefPubMed
38.
go back to reference Pandiella A, Massague J: Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process. Proc Natl Acad Sci USA 1991, 88:1726–1730.CrossRefPubMedPubMedCentral Pandiella A, Massague J: Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process. Proc Natl Acad Sci USA 1991, 88:1726–1730.CrossRefPubMedPubMedCentral
39.
go back to reference Meyer-Hoffert U, Wingertszahn J, Wiedow O: Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation. J Invest Dermatol 2004, 123:338–345.CrossRefPubMed Meyer-Hoffert U, Wingertszahn J, Wiedow O: Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation. J Invest Dermatol 2004, 123:338–345.CrossRefPubMed
40.
go back to reference Taipale J, Lohi J, Kovanen PT, Kestki-Oja J: Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial cells. J Biol Chem 1995, 270:4689–4696.CrossRefPubMed Taipale J, Lohi J, Kovanen PT, Kestki-Oja J: Human mast cell chymase and leukocyte elastase release latent transforming growth factor-beta 1 from the extracellular matrix of cultured human epithelial cells. J Biol Chem 1995, 270:4689–4696.CrossRefPubMed
41.
go back to reference Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D: Loss of integrin αvβ6-mediated TGF-β activation causes MMP-12-dependent emphysema. Nature 2003, 422:169–173.CrossRefPubMed Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G, Glick A, Sheppard D: Loss of integrin αvβ6-mediated TGF-β activation causes MMP-12-dependent emphysema. Nature 2003, 422:169–173.CrossRefPubMed
Metadata
Title
Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models
Authors
Monica Lucattelli
Barbara Bartalesi
Eleonora Cavarra
Silvia Fineschi
Benedetta Lunghi
Piero A Martorana
Giuseppe Lungarella
Publication date
01-12-2005
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2005
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-6-83

Other articles of this Issue 1/2005

Respiratory Research 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine